Staff
Privately-held PharmaCann Inc. is buying Colorado-based LivWell Enlightened Health for an undisclosed amount. Once the deal is closed, PharmaCann and LivWell would operate approximately 60 dispensaries and 11 cultivation and production facilities across eight states.
LivWell has grown from a single location to a multi-state cannabis company with operations in Colorado and Michigan. LivWell is a vertically integrated seed-to-sale cannabis retailer. In addition to cultivating cannabis, LivWell researches, extracts, and manufactures its own brands to consistently bring its customers quality products across multiple categories including topicals, edibles, tinctures, CBD pet tinctures, concentrates, and vaporizers.
“It is a privilege to join teams with LivWell, one of the longest-tenured cannabis operators in the industry, with a shared commitment to improving people’s lives through cannabis,” said Brett Novey, CEO of PharmaCann. “This transformative merger significantly increases PharmaCann’s presence in the second and third-largest cannabis markets in the U.S. and provides a strong foundational team and operational platform for PharmaCann’s further expansion into new states. Together we will implement best practices across all of our operations and build upon LivWell’s strong brand and expertise in producing low-cost, high-quality products.”
At one time, MedMen was going to buy PharmaCann, but that deal fell through in 2019. Since then the company has remained private and currently operates four medical cannabis retail stores and a cultivation facility in New York. In June 2021, Pharmacann raised almost $80 million in a private offering of Senior Secured Notes. In August it was reported that the company submitted paperwork for an IPO to U.S. and Canadian regulators. The company reportedly did $75 million in revenues in 2019 and is said to have doubled that number in 2020.
“We are excited for this partnership with a stalwart of the U.S. cannabis industry,” said John Lord, Founder, and CEO of LivWell Enlightened Health. “PharmaCann’s undeniable financial expertise and LivWell’s proven operational leadership makes this merger the perfect combination to further the patient and customer experience on an expanding national level.” The company said it expects that John Lord will join the PharmaCann Board of Directors following the closing of the transaction.
Canaccord Genuity Corp. served as financial advisor and Perkins Coie, LLP served as legal advisor to PharmaCann. Canaccord Genuity Corp. also provided a fairness opinion to the board of directors of PharmaCann.
